9405 related articles for article (PubMed ID: 1875350)
1. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.
Cushman M; Nagarathnam D; Gopal D; Chakraborti AK; Lin CM; Hamel E
J Med Chem; 1991 Aug; 34(8):2579-88. PubMed ID: 1875350
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents.
Cushman M; Nagarathnam D; Gopal D; He HM; Lin CM; Hamel E
J Med Chem; 1992 Jun; 35(12):2293-306. PubMed ID: 1613753
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
[TBL] [Abstract][Full Text] [Related]
6. Interactions of tubulin with potent natural and synthetic analogs of the antimitotic agent combretastatin: a structure-activity study.
Lin CM; Singh SB; Chu PS; Dempcy RO; Schmidt JM; Pettit GR; Hamel E
Mol Pharmacol; 1988 Aug; 34(2):200-8. PubMed ID: 3412321
[TBL] [Abstract][Full Text] [Related]
7. Tubulin-interactive stilbene derivatives as anticancer agents.
Mikstacka R; Stefański T; Różański J
Cell Mol Biol Lett; 2013 Sep; 18(3):368-97. PubMed ID: 23818224
[TBL] [Abstract][Full Text] [Related]
8. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of 1,6,7,8-substituted 2-(4'-substituted phenyl)-4-quinolones and related compounds: identification as antimitotic agents interacting with tubulin.
Kuo SC; Lee HZ; Juang JP; Lin YT; Wu TS; Chang JJ; Lednicer D; Paull KD; Lin CM; Hamel E
J Med Chem; 1993 Apr; 36(9):1146-56. PubMed ID: 8387598
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of mustard derivatives of combretastatins.
Coggiola B; Pagliai F; Allegrone G; Genazzani AA; Tron GC
Bioorg Med Chem Lett; 2005 Aug; 15(15):3551-4. PubMed ID: 15963722
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Cytotoxicity Studies of Stilbene Long-Chain Fatty Acid Conjugates.
Wong T; Narayanan S; Brown DP; Chen ZS
J Nat Prod; 2020 May; 83(5):1563-1570. PubMed ID: 32243160
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin.
Pinney KG; Mejia MP; Villalobos VM; Rosenquist BE; Pettit GR; Verdier-Pinard P; Hamel E
Bioorg Med Chem; 2000 Oct; 8(10):2417-25. PubMed ID: 11058036
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of New N
Elmeligie S; Khalil NA; Ahmed EM; Emam SH; Zaitone SA
Biol Pharm Bull; 2016; 39(10):1611-1622. PubMed ID: 27725438
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxic evaluation and molecular docking study of 2-alkylthio-4-(2,3,4-trimethoxyphenyl)-5-aryl-thiazoles as tubulin polymerization inhibitors.
Salehi M; Amini M; Ostad SN; Riazi GH; Assadieskandar A; Shafiei B; Shafiee A
Bioorg Med Chem; 2013 Dec; 21(24):7648-54. PubMed ID: 24238904
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
Pettit GR; Singh SB; Boyd MR; Hamel E; Pettit RK; Schmidt JM; Hogan F
J Med Chem; 1995 May; 38(10):1666-72. PubMed ID: 7752190
[TBL] [Abstract][Full Text] [Related]
18. Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents.
Gwaltney SL; Imade HM; Barr KJ; Li Q; Gehrke L; Credo RB; Warner RB; Lee JY; Kovar P; Wang J; Nukkala MA; Zielinski NA; Frost D; Ng SC; Sham HL
Bioorg Med Chem Lett; 2001 Apr; 11(7):871-4. PubMed ID: 11294380
[TBL] [Abstract][Full Text] [Related]
19. Computational and molecular modeling evaluation of the structural basis for tubulin polymerization inhibition by colchicine site agents.
ter Haar E; Rosenkranz HS; Hamel E; Day BW
Bioorg Med Chem; 1996 Oct; 4(10):1659-71. PubMed ID: 8931935
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
